BPA for kymriah
Ended Awarded Last action
- Contract number
- 36E79720A0019
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 3 $850,638 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $850,638 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 4% used
- $21,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The BPA, valued at $21.5 million, is for the procurement of Kymriah, a specialized cell therapy cancer treatment. Kymriah is a chimeric antigen receptor T-cell (CAR-T) therapy provided by Novartis under the company's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $5.4 billion and runs through August 2026. The BPA supports the delivery of Kymriah to various VA Integrated Service Networks (VISNs) and medical centers to treat veterans. The contract does not have any set-aside designations. To date, Novartis has received over $2.8 million in Kymriah orders from the VA through this BPA and other contract vehicles.
The VA National Acquisition Center has issued multiple task orders under the BPA, ranging from $283,526.57 to $283,555.92, for the delivery of Kymriah to VA facilities in New Jersey, Florida, and other locations. These BPA call orders are firm-fixed-price contracts awarded under Novartis' FSS contract. The contracted services aim to provide specialized cancer therapy treatments to support the VA's healthcare programs for veterans through the procurement of Kymriah, a key pharmaceutical product in Novartis' portfolio of advanced medical treatments.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pharmaceutical - tisagenlecleucel (KYMRIAH) | Veterans Integrated Service Network 9 (VHA) | $283,556 | |
| Kymriah | Veterans Integrated Service Network 9 (VHA) | $283,556 | |
| Kymriah medication | Veterans Integrated Service Network 17 (VHA) | $283,527 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 14
Quick answers
Who was awarded contract 36E79720A0019?
36E79720A0019 was awarded to Novartis Pharmaceuticals Corporation by National Acquisition Center (Headquarters) on September 30, 2020.
How much is contract 36E79720A0019 worth?
Orders under 36E79720A0019 have obligated $850,638. 36E79720A0019's own ceiling is $21,500,000.
How many orders have been placed under contract 36E79720A0019?
3 orders have been placed under 36E79720A0019, the latest on March 8, 2021.
Who can order from contract 36E79720A0019?
36E79720A0019 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79720A0019 under another contract?
Yes. 36E79720A0019 is a blanket purchase agreement under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79720A0019 competed?
The extent of competition for 36E79720A0019 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV